Vitronectin-derived cell culture substrate for maintaining human pluripotent stem cells in a substantially undifferentiated state
Vitronectin-derived cell culture substrates and methods of using the same for culturing pluripotent stem cells are presented. Also provided herein are defined culture systems for maintaining human pluripotent stem cells in a substantially undifferentiated state, where the defined culture system comprises human pluripotent stem cells, a defined culture medium, and at least one polypeptide selected from the group consisting of residues 43 to 378 of SEQ ID NO:1 and residues 45 to 378 of SEQ ID NO:1, and where the defined culture medium comprises insulin, selenium, transferrin, L-ascorbic acid, FGF2, DMEM/F12, NaHCO 3 , and one of TGFβ and NODAL.
1. A defined culture system for maintaining human pluripotent stem cells in a substantially undifferentiated state, the defined culture system comprising human pluripotent stem cells, a defined culture medium, and at least one polypeptide selected from the group consisting of residues 43 to 378 of SEQ ID NO:1 and residues 45 to 378 of SEQ ID NO:1, wherein the defined culture medium comprises insulin, selenium, transferrin, L-ascorbic acid, FGF2, DMEM/F12, NaHCO 3 , and one of TGFβ and NODAL.
2. The system of claim 1 , wherein the defined culture system is capable of maintaining human pluripotent stem cells in a substantially undifferentiated state for at least 20 passages in the absence of feeder cell support.
3. The system of claim 1 , wherein the defined culture system is capable of maintaining human pluripotent stem cells in a substantially undifferentiated state for at least 25 passages in the absence of feeder cell support.
4. The system of claim 1 , wherein the defined culture system is substantially free of any xenogenic component with regard to the stem cells.
5. The system of claim 1 , wherein the defined culture medium consists essentially of insulin, selenium, transferrin, L-ascorbic acid, FGF2, DMEM/F12, NaHCO 3 , and one of TGFβ and NODAL.
6. A cell culture comprising:
undifferentiated human pluripotent stem cells;
a defined cell culture medium suitable for proliferation of the pluripotent stem cells, wherein the defined culture medium comprises insulin, selenium, transferrin, L-ascorbic acid, FGF2, DMEM/F12, NaHCO 3 , and one of TGFβ and NODAL; and
a substrate comprising at least one polypeptide selected from the group consisting of residues 43 to 378 of SEQ ID NO:1 and residues 45 to 378 of SEQ ID NO:1.
7. The cell culture of claim 6 , wherein the polypeptide is SEQ ID NO:2.
8. The cell culture of claim 6 , wherein the polypeptide is SEQ ID NO:4.
9. The cell culture of claim 6 , wherein the substrate is substantially free of any xenogenic component with regard to the pluripotent stem cells.
10. The cell culture of claim 6 , wherein the defined culture medium consists essentially of insulin, selenium, transferrin, L-ascorbic acid, FGF2, DMEM/F12, NaHCO 3 , and one of TGFβ and NODAL.
11. A defined culture system for maintaining human pluripotent stem cells in a substantially undifferentiated state, the defined culture system comprising (i) a defined culture medium, wherein the defined culture medium comprises insulin, selenium, transferrin, L-ascorbic acid, FGF2, DMEM/F12, NaHCO 3 , and one of TGFβ and NODAL; and (ii) a vessel comprising a substrate having at least one polypeptide selected from the group consisting of residues 43 to 378 of SEQ ID NO:1 and residues 45 to 378 of SEQ ID NO:1 attached thereto.
12. A defined culture system for maintaining human pluripotent stem cells in a substantially undifferentiated state, the defined culture system comprising (i) a defined culture medium; and (ii) a vessel comprising a substrate having at least one polypeptide selected from the group consisting of residues 43 to 378 of SEQ ID NO:1 and residues 45 to 378 of SEQ ID NO:1 attached thereto.
13. The system of claim 12 , wherein the vessel is a cell culture plate.
14. The system of claim 12 , further comprising human pluripotent stem cells.
15. The system of claim 12 , wherein the defined culture system is substantially free of any xenogeneic component with regard to the human pluripotent stem cells.
16. The system of claim 12 , wherein the defined culture medium comprises insulin, selenium, transferrin, L-ascorbic acid, FGF2, DMEM/F12, NaHCO 3 , and one of TGFβ and NODAL.
17. The system of claim 11 , wherein the defined culture medium consists essentially of insulin, selenium, transferrin, L-ascorbic acid, FGF2, DMEM/F12, NaHCO 3 , and one of TGFβ and NODAL.
18. The system of claim 12 , wherein each polypeptide is present on the substrate in an amount sufficient to maintain human pluripotent stem cells in a substantially undifferentiated state for at least 20 passages in the absence of feeder cell support.
19. The system of claim 12 , wherein each polypeptide is present on the substrate in an amount sufficient to maintain human pluripotent stem cells in a substantially undifferentiated state for at least 25 passages in the absence of feeder cell support.
20. The system of claim 12 , wherein the defined culture medium consists essentially of insulin, selenium, transferrin, L-ascorbic acid, FGF2, DMEM/F12, NaHCO 3 , and one of TGFβ and NODAL.